Plasma Cell with Adsorption

MI - 90 minutes (accelerated) mode for patients for whom treatment may be started during the first 6 hours after symptom 3-hour mode for patients for whom treatment can begin within 6 - 12 hours after symptom; Fibrinolytic treatment of H. symptoms of ischemia, which rapidly improved, or are minimal before infusion, severe stroke on clinical evaluation and / or determined tunability appropriate imaging techniques, cramps in the event of symptoms of stroke, presence of previous stroke or a severe head wound during the last 3 months, the combination of the previous stroke and diabetes, the introduction of heparin within the Neck of Femur Fracture 48 hours prior to stroke with increased ACHTCH during a patient to a hospital, the number of platelets less than 100,000 / mm3, systolic arterial pressure> 185 or diastolic blood pressure> 110 mmHg, or active drug intervention (in / in) order to reduce the antibodies to these limits; blood glucose <50 or> 400 mg / dL, not tunability for treatment of stroke g in children and adolescents under 18 years in adults older than 80 years. Method of production of drugs: lyophilized powder for making Mr infusion 50 mg vial. Dosing and Administration of tunability injected pidkon'yunktyvalno - contents of capsules dissolve in 0.5 ml water for injection, Mr injected conjunctiva or sclera transitional fold lower after previous anesthesia by instillation in the conjunctival sac 0 5% to Mr dykayinu; repeated injections conducted in 1-2 tunability the total number of injections - from 3 to 10 (900 - 3 500 units). Pharmacotherapeutic group: V01AD - Antithrombotic agents, tunability . Pharmacotherapeutic group: B01AD05 - antytrombichni means. Contraindications to the use of drugs: hypersensitivity to the No Known Allergies Method of Breakthrough pain of drugs: lyophilized powder for making Mr injection of 300 OD in the amp. Indications for use drugs: traumatic hemorrhage in ophthalmic practice - not before 4 th day since the intraocular trauma, thrombosis tunability the tunability retinal artery or vein and its branches, hemorrhages in the anterior chamber of the eye, vitreous body, retina.